chr19-35536854-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014364.5(GAPDHS):āc.109G>Cā(p.Glu37Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000682 in 1,613,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014364.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GAPDHS | NM_014364.5 | c.109G>C | p.Glu37Gln | missense_variant | 2/11 | ENST00000222286.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GAPDHS | ENST00000222286.9 | c.109G>C | p.Glu37Gln | missense_variant | 2/11 | 1 | NM_014364.5 | P1 | |
GAPDHS | ENST00000585510.1 | c.-96G>C | 5_prime_UTR_variant | 1/6 | 3 | ||||
GAPDHS | ENST00000586334.1 | c.68-1453G>C | intron_variant, NMD_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152028Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000956 AC: 24AN: 251150Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135726
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1461590Hom.: 0 Cov.: 31 AF XY: 0.0000633 AC XY: 46AN XY: 727108
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152028Hom.: 0 Cov.: 31 AF XY: 0.0000808 AC XY: 6AN XY: 74238
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2021 | The c.109G>C (p.E37Q) alteration is located in exon 2 (coding exon 2) of the GAPDHS gene. This alteration results from a G to C substitution at nucleotide position 109, causing the glutamic acid (E) at amino acid position 37 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at